Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Picaud

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Angewandte Chemie (International Ed. in English)|May 14, 2014
A series of potent CREBBP bromodomain ligands reveals an induced-fit pocket stabilized by a cation-π interactionTimothy P C Rooney, Panagis Filippakopoulos, Oleg Fedorov, et al.
Journal of the American Chemical Society|June 20, 2014
Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomainsDuncan A Hay, Oleg Fedorov, Sarah Martin, et al.
Science Advances|December 25, 2015
Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenanceOleg Fedorov, Josefina Castex, Cynthia Tallant, et al.
Bioorganic & Medicinal Chemistry|May 20, 2018
BET bromodomain ligands: Probing the WPF shelf to improve BRD4 bromodomain affinity and metabolic stabilityLaura E Jennings, Matthias Schiedel, David S Hewings, et al.
Nature|September 28, 2010
Selective inhibition of BET bromodomainsPanagis Filippakopoulos, Jun Qi, Sarah Picaud, et al.
Journal of Medicinal Chemistry|April 27, 2016
Identification of a Chemical Probe for Family VIII Bromodomains through Optimization of a Fragment HitBrian S Gerstenberger, John D Trzupek, Cynthia Tallant, et al.
Journal of Medicinal Chemistry|July 13, 2021
Controlling Intramolecular Interactions in the Design of Selective, High-Affinity Ligands for the CREBBP BromodomainMichael Brand, James Clayton, Mustafa Moroglu, et al.
Cancer Research|November 11, 2015
Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia TherapySarah Picaud, Oleg Fedorov, Angeliki Thanasopoulou, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Angewandte Chemie (International Ed. in English)|May 14, 2014
A series of potent CREBBP bromodomain ligands reveals an induced-fit pocket stabilized by a cation-π interactionTimothy P C Rooney, Panagis Filippakopoulos, Oleg Fedorov, et al.
Journal of the American Chemical Society|June 20, 2014
Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomainsDuncan A Hay, Oleg Fedorov, Sarah Martin, et al.
Science Advances|December 25, 2015
Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenanceOleg Fedorov, Josefina Castex, Cynthia Tallant, et al.
Bioorganic & Medicinal Chemistry|May 20, 2018
BET bromodomain ligands: Probing the WPF shelf to improve BRD4 bromodomain affinity and metabolic stabilityLaura E Jennings, Matthias Schiedel, David S Hewings, et al.
Nature|September 28, 2010
Selective inhibition of BET bromodomainsPanagis Filippakopoulos, Jun Qi, Sarah Picaud, et al.
Journal of Medicinal Chemistry|April 27, 2016
Identification of a Chemical Probe for Family VIII Bromodomains through Optimization of a Fragment HitBrian S Gerstenberger, John D Trzupek, Cynthia Tallant, et al.
Journal of Medicinal Chemistry|July 13, 2021
Controlling Intramolecular Interactions in the Design of Selective, High-Affinity Ligands for the CREBBP BromodomainMichael Brand, James Clayton, Mustafa Moroglu, et al.
Cancer Research|November 11, 2015
Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia TherapySarah Picaud, Oleg Fedorov, Angeliki Thanasopoulou, et al.
Pageof 6